How is Cognizant building a global culture that values collaboration, innovation, and client focus?

Apr 7, 2021 ... Cognizant to Team with Celonis to Drive Seamless Transformation and Improve Customer Services ... Cognizant today announced its collaboration with ... The Element i+™ immunodiagnostic analyzer supports diagnostic needs with total T4, cortisol, progesterone, cTSH, cCRP, and the Nu.Q® cancer test. The intrinsic value of one CTSH stock under the Base Case scenario is 84.94 USD. Compared to the current market price of 72.9 USD, Cognizant Technology ... Drive faster, predictive and proactive decision-making. ... Boost operational efficiency, optimize costs and speed product development. ... Reimagine the customer ... May 13, 2021 ... Cathepsin H (CTSH) is a type 1 diabetes (T1D) risk gene; large-scale genetic and epidemiological studies found that T1D genetic risk ... The Cognizant Technology's current Enterprise Value Over EBITDA is estimated to increase to 20.54. The Cognizant Technology's current Enterprise Value Multiple ... ... (cTSH; thyroid stimulating hormone), and thyroglobulin antibodies (TgAA). The cTSH test provides much needed information in any attempt to diagnose ... Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can ... Welcome to careers at Cognizant. Where you're empowered to combine your passions with our reach to engineer a smarter, more connected world. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, ...